Medpace Voice

In January 2025, the FDA released updated guidance titled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.” The FDA...

Every cancer journey is unique—shaped by the individual, the disease, and the evolving landscape of treatment.

Medpace medical, regulatory, and biostatistics experts identify key differences between the FDA’s 2007 and 2025 guidance documents on developing products...

Watch the on-demand Rare Disease Day webinar to explore strategies for cross-border patient enrollment and retention.

In the following video series, Medpace experts across North America, Europe, Latin America, and Asia Pacific will explore how our ID&V team enhances the success…

ASH 2024 Highlights:
Advancing Therapeutic Scalability, Precision Medicine, and Next-Gen Trial Designs

Exploring Advancements in Personalized Medicine, Sexual Health, Essential Endpoints, and Health Equity in Clinical Trials  

Breast cancer persists as a critical global health challenge, with an estimated 1 in 8 women facing a diagnosis over...

Medpace is pleased to announce the addition of a new ophthalmology expert, Dr. Karen Klugo, to the medical leadership team. 

In this webinar, Medpace neuroscience clinical trial experts will explore strategies for successfully conducting psychiatry clinical trials.